
Loading, please wait...

Loading, please wait...

A Cochrane systematic review assessed randomized trials of pulmonary rehabilitation initiated after COPD exacerbations. The review found that rehabilitation improved important patient-centered outcomes, including exercise capacity and health-related quality of life, and the evidence available at the time suggested substantial reductions in subsequent hospital admissions. The review is particularly valuable because it places individual rehabilitation trials into a broader evidence framework and supports the concept that rehabilitation can be clinically meaningful after an exacerbation rather than only during stable disease. This is directly aligned with the NAPCON emphasis on structured rehabilitation, exercise prescription and the six-minute walk test. For clinicians, the practical implication is to consider referral early enough to capture the recovery window while ensuring the patient is medically stable and able to participate. The review also highlights the heterogeneity of rehabilitation programs, which means that “pulmonary rehabilitation” is not a single standardized intervention delivered identically everywhere. Program structure, exercise intensity, supervision and follow-up all affect implementation. The article is useful when discussing why rehabilitation should be integrated into COPD pathways rather than offered only after repeated treatment failures.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Cochrane systematic review assessed randomized trials of pulmonary rehabilitation initiated after COPD exacerbations. The review found that rehabilitation improved important patient-centered outcomes, including exercise capacity and health-related quality of life, and the evidence available at the time suggested substantial reductions in subsequent hospital admissions. The review is particularly valuable because it places individual rehabilitation trials into a broader evidence framework and supports the concept that rehabilitation can be clinically meaningful after an exacerbation rather than only during stable disease. This is directly aligned with the NAPCON emphasis on structured rehabilitation, exercise prescription and the six-minute walk test. For clinicians, the practical implication is to consider referral early enough to capture the recovery window while ensuring the patient is medically stable and able to participate. The review also highlights the heterogeneity of rehabilitation programs, which means that “pulmonary rehabilitation” is not a single standardized intervention delivered identically everywhere. Program structure, exercise intensity, supervision and follow-up all affect implementation. The article is useful when discussing why rehabilitation should be integrated into COPD pathways rather than offered only after repeated treatment failures.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back